Changing the treatment paradigm of hyperkalaemia management to enable and optimize renin-angiotensin-aldosterone system inhibitors therapy.
Session:
Dilemma in cardio-renal patients: hyperkalaemia vs renin-angiotensin-aldosterone system inhibitors?
Topic:
Chronic Heart Failure, Other
Speaker:
Professor B. Pitt (Ann Arbor, US)
Sponsored by Vifor Pharma
Event:
Heart Failure 2018
Congress Presentation
About the speaker
Professor Bertram Pitt
University of Michigan, Ann Arbor (United States of America)
24
presentations
0
follower
4 more presentations in this session
Dilemma in cardio-renal patients: hyperkalaemia vs renin-angiotensin-aldosterone system inhibitors? - Introduction
Speaker: Professor J. Cleland (Glasgow, GB)
Renin-angiotensin-aldosterone system inhibitors therapy benefits and challenges in cardio-renal patients.
Speaker: Professor P. Van Der Meer (Groningen, NL)
Dilemma in cardio-renal patients: hyperkalaemia vs renin-angiotensin-aldosterone system inhibitors? - Summary and conclusions
Speaker: Professor J. Cleland (Glasgow, GB)
Access the full session
Dilemma in cardio-renal patients: hyperkalaemia vs renin-angiotensin-aldosterone system inhibitors?
Speakers:
Professor B. Pitt, Professor J. Cleland, Professor P. Van Der Meer, Professor J. Butler, Professor J. Cleland
About the event
ESC 365 is supported by
